Recent advances in ocular graft-versus-host disease

被引:13
|
作者
Cheng, Xianjing [1 ,2 ]
Huang, Ruihao [1 ]
Huang, Shiqin [1 ]
Fan, Wei [3 ]
Yuan, Rongdi [3 ]
Wang, Xiaoqi [1 ]
Zhang, Xi [1 ,2 ,4 ]
机构
[1] Army Med Univ, Xinqiao Hosp, State Key Lab Trauma Burns & Combined Injury, Med Ctr Hematol, Chongqing, Peoples R China
[2] Chongqing Univ, Sch Med, Chongqing, Peoples R China
[3] Army Med Univ, Xinqiao Hosp, Dept Ophthalmol, Chongqing, Peoples R China
[4] Jinfeng Lab, Chongqing, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
ocular graft-versus-host-disease; clinical characteristics; the pathogenic mechanism; novel therapeutic targets; tear biomarkers; STEM-CELL TRANSPLANTATION; SERUM EYE DROPS; CONSENSUS DEVELOPMENT PROJECT; MEIBOMIAN GLAND DYSFUNCTION; MESENCHYMAL STROMAL CELLS; DRY EYE; LACRIMAL GLAND; CLINICAL-TRIALS; LONGITUDINAL ANALYSIS; RANDOMIZED-TRIAL;
D O I
10.3389/fimmu.2023.1092108
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ocular graft-versus-host-disease (GVHD) remains a significant clinical complication after allogeneic hematopoietic stem cell transplantation. Impaired visual function, pain, and other symptoms severely affect affected individuals' quality of life. However, the diagnosis of and therapy for ocular GVHD involve a multidisciplinary approach and remain challenging for both hematologists and ophthalmologists, as there are no unified international criteria. Through an exploration of the complex pathogenesis of ocular GVHD, this review comprehensively summarizes the pathogenic mechanism, related tear biomarkers, and clinical characteristics of this disease. Novel therapies based on the mechanisms are also discussed to provide insights into the ocular GVHD treatment.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Ocular graft-versus-host disease (oGVHD): From AtoZ
    Soleimani, Mohammad
    Sharif, Pouya Mahdavi
    Cheraqpour, Kasra
    Koganti, Raghuram
    Masoumi, Ahmad
    Baharnoori, Seyed Mahbod
    Salabati, Mirataollah
    Djalilian, Ali R.
    SURVEY OF OPHTHALMOLOGY, 2023, 68 (04) : 697 - 712
  • [42] PENETRATING KERATOPLASTY IN SEVERE OCULAR GRAFT-VERSUS-HOST DISEASE
    HEATH, JD
    ACHESON, JF
    SCHULENBURG, WE
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (08) : 525 - 526
  • [43] Ocular Graft-versus-Host Disease Underdiagnosis: A Survey Study
    Colarusso, Bradley A.
    Bligdon, Shannon M.
    Ganjei, Allen Y.
    Kwok, Alan
    Brocks, Daniel
    Luo, Zhonghui K.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 1419 - 1426
  • [44] PROSE Treatment in Atypical Ocular Graft-Versus-Host Disease
    Chiu, Gloria B.
    Theophanous, Christos
    Irvine, John A.
    OPTOMETRY AND VISION SCIENCE, 2016, 93 (11) : 1439 - 1439
  • [45] GRAFT-VERSUS-HOST DISEASE OR GRAFT-VERSUS-HOST LIKE SYNDROME
    BEYER, J
    SCHWERDTFEGER, R
    SIEGERT, W
    BLOOD, 1992, 80 (11) : 2948 - 2949
  • [46] Ocular Surface Disease Characteristics in Patients with Ocular Graft-versus-Host Disease (GVHD).
    Shikari, Hasanain
    Saboo, Ujwala
    Dana, Reza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [47] Ocular pain in ocular graft-versus-host disease patients with neurotrophic keratopathy
    Wang, Shudan
    Singh, Rohan Bir
    Yuksel, Erdem
    Musayeva, Aytan
    Sinha, Shruti
    Taketani, Yukako
    Dohlman, Thomas H.
    Dana, Reza
    OCULAR SURFACE, 2022, 26 : 142 - 147
  • [48] Concurrence of Ocular Cicatricial Pemphigoid in Chronic Ocular Graft-Versus-Host Disease
    Taketani, Yukako
    Dehghani, Shima
    Sinha, Shruti
    Freitag, Suzanne K.
    Papaliodis, George
    Foster, Stephen
    Dohlman, Thomas H.
    Dana, Reza
    CORNEA, 2024, 43 (03) : 387 - 390
  • [49] New advances in acute graft-versus-host disease prophylaxis
    Davies, JK
    Lowdell, MW
    TRANSFUSION MEDICINE, 2003, 13 (06) : 387 - 397
  • [50] Mouse models of graft-versus-host disease: advances and limitations
    Schroeder, Mark A.
    DiPersio, John F.
    DISEASE MODELS & MECHANISMS, 2011, 4 (03) : 318 - 333